Abstract
Purpose
This study was done to investigate the correlation between the apparent diffusion coefficient (ADC) and prognostic factors of breast cancer.
Materials and methods
From January 2008 to June 2011, all consecutive patients with breast cancer who underwent breast magnetic resonance imaging (MRI) and subsequent surgery in our hospital were enrolled in our study. The MRI protocol included a diffusion-weighted imaging sequence with b values of 0 and 1,000 s/mm2. For each target lesion in the breast, the ADC value was compared with regard to major prognostic factors: histology, tumour grade, tumour size, lymph node status, and age.
Results
A total of 289 patients with a mean age of 53.49 years were included in the study. The mean ADC value of malignant lesions was 1.02 × 10−3 mm2/s. In situ carcinomas, grade 1 lesions, and tumours without lymph nodal involvement had mean ADC values that were significantly higher than those of invasive carcinomas (p = 0.009), grade 2/3 lesions (p < 0.001), and tumours with nodal metastases (p = 0.001). No significant differences were observed in ADC values among tumours of different sizes or among patient age groups.
Conclusions
ADC values appear to correlate with tumour grade and some major prognostic factors.
Similar content being viewed by others
References
Raka EA, Ellis IO (2011) Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristics. Adv Anat Pathol 18:255–267
Rakha EA, Reis-Filho JS, Baehner F et al (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12:207
Bone B, Aspelin P, Bronge L, Veress B (1998) Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 39:279–284
Jinguji J, Kajiya Y, Kamimura K et al (2006) Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors. Breast Cancer 13:64–73
Mussurakis S, Buckley DL, Horsman A (1997) Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 70:446–451
Szabo BK, Aspelin P, Kristoffersen Wiberg M et al (2003) Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 13:2425–2435
Partridge SC, DeMartini WB, Kurland BF et al (2009) Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR 193:1716–1722
Peters NHGM, Vincken KL, Van Den Bosch MAAJ et al (2010) Quantitative diffusion-weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values. J Magn Reson Imaging 31:1100–1105
Rahbar H, Partridge SC, Eby PR et al (2011) Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 21:2011–2019
Kim SH, Cha ES, Kim HS et al (2009) Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging 30:615–620
Costantini M, Belli P, Rinaldi P et al (2010) Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumor aggressiveness. Clin Radiol 65:1005–1012
Martincich L, Deantoni V, Bertotto I et al (2012) Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 22:1519–1528
Choi SY, Chang YW, Park HJ et al (2012) Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br J Radiol 85:474–479
Choi BB, Kim SH, Kang BJ et al (2012) Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma. World J Surg Oncol 10:126
Nakajo M, Kajiya Y, Kaneko T et al (2010) FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging 37:2011–2020
Razek AA, Gaballa G, Denewer A, Nada N (2010) Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed 23:619–623
Colagrande S, Carbone SF, Carusi LM et al (2006) Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med 111:392–419
Kuroki Y, Nasu K (2008) Advances in breast MRI: diffusion-weighted imaging of the breast. Breast Cancer 15:212–217
Kul S, Cansu A, Alhan E et al (2011) Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR 196:210–217
Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410
McGuire WL (1991) Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst 83:154–155
Rakha EM, El-Sayed ME, Lee AHS et al (2008) Prognostic significance of Nottingham Histologic Grade in invasive breast carcinoma. J Clin Oncol 26:3153–3158
Adedayo A, Onitilo MD, Engel JM et al (2009) Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7:4–13
Cianfrocca M, Gradishar W (2009) New molecular classifications of breast cancer. CA Cancer J Clin 59:303–313
Desmedt C, Haibe-Kains B, Wirapati P et al (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 14:123–127
Fernandes RCM, Bevilacqua JLB, Soares IC et al (2009) Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas. Histopathology 55:346–352
Habibi G, Leung S, Law JH et al (2008) Redefining prognostic factors for breast cancer: yB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes. Breast Cancer Res 10:R86
Weigelt B, Horlings HM, Kreike B et al (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 21:141–150
Belli P, Costantini M, Ierardi C et al (2011) Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment. Breast J 17:610–619
National Research Ethics Service (2008) Approval for medical devices research: guidance for researchers, manufacturers, research ethics, committees and NHRR&D offices (Version 2). National Patients Safety Agency, London
Cheng L, Bai Y, Zhang J et al (2013) Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement. Tumor Biol 34:1537–1545
Parsian S, Rahbar H, Allison KH et al (2012) Nonmalignant breast lesions: aDCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology 265:696–706
Tavassoli FA, Devilee P (2003) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. IARC Press, Lyon
Elston CW (2005) Classification and grading of invasive breast carcinoma. Verh Dtsch Ges Pathol 89:35–44
Cirri P, Chiarugi P (2011) Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res 1:482
Bertos NR, Park M (2011) Breast cancer-one term, many entities? J Clin Invest 121:3789
Tabar L, Fagerberg G, Day NE et al (1992) Breast cancer treatment and natural history: new insights from results of screening. Lancet 339:412–414
Bertrand KA, Tamimi RM, Jensen MR et al (2013) Mammograohic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res 15:R104
Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective color of breast cancer patients. Breast Cancer Res 9:R6
Conflict of interest
All authors Paolo Belli, Melania Costantini, Enida Bufi, Giuseppe Giovanni Giardina, Pierluigi Rinaldi, Gianluca Franceschini, and Lorenzo Bonomo declare that they have not conflict of interest.
Ethical statement
IRB approval with waiver of informed consent and/or conformity to the Declaration of Helsinki is in compliance with the Ethical standards requirements.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Belli, P., Costantini, M., Bufi, E. et al. Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors. Radiol med 120, 268–276 (2015). https://doi.org/10.1007/s11547-014-0442-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-014-0442-8